Summary
The biological properties of a novel compound 353C with high activity againstTrypanosoma cruzi, are described. The compound was about 10 times and 20 times more effective than either benznidazole or nifurtimox respectively, in producing radical cure in mice. 353C had a long half-life and showed anti-trypanosomal properties when given to mice at weekly intervals.
Similar content being viewed by others
References
J.A. Walsh and K.S. Warren, New Engl. J. Med.301, 967 (1979).
J.R. Cançado and Z. Brener, in:Trypanosoma cruzi e Doença de Chagas, p. 362. Ed. Z. Brener and Z. Andrade. Guanabara Koogan SA, Rio de Janeiro Brazil 1979.
E. Beveridge, I.C. Caldwell, V.S. Latter, R.A. Neal, V. Udall and M.M. Waldron, Trans. R. Soc. trop. Med. Hyg.74, 43 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barrett, P.A., Beveridge, E., Bull, D. et al. The efficacy of a novel compound, (E)-1-(4′-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene againstTrypanosoma cruzi in mice. Experientia 38, 338–339 (1982). https://doi.org/10.1007/BF01949378
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01949378